How should I give a patient an intravenous infusion of 5% dextrose in 0.45% sodium chloride with 20 mEq potassium chloride at a rate of 175 mL per hour?

Administration of D5 1/2 NS with KCl 20mEq at 175 mL/hr

This infusion should be administered through a peripheral or central IV line with careful attention to proper mixing, appropriate monitoring, and awareness that this rate (175 mL/hr) may be too rapid for certain patient populations, particularly pediatric patients.

Key Safety Considerations

Potassium Administration Safety

The potassium concentration in this solution is approximately 114 mEq/L (20 mEq in 175 mL/hr), which is a moderately concentrated solution. Critical safety measures include:

• Never administer as a rapid bolus - the 175 mL/hr rate translates to approximately 20 mEq of potassium per hour, which is at the upper limit of safe peripheral administration 1
• Use a calibrated infusion pump - this is mandatory for potassium-containing solutions 1
• Continuous cardiac monitoring is strongly recommended for patients receiving highly concentrated potassium solutions, especially those on digitalis 1
• Central venous administration is preferred when possible for concentrated potassium solutions to ensure thorough dilution and avoid extravasation 1

Critical Mixing Requirement

The bag MUST be vigorously mixed after adding potassium chloride. Research demonstrates that incomplete mixing of KCl in IV bags, particularly flexible PVC bags, can result in dangerously variable concentrations - ranging from 71 mEq/L at the beginning of outflow to 11.8 mEq/L at the end, with maximum concentrations up to 1000 times greater than minimum in poorly mixed containers 2. Vigorous purposeful mixing greatly improves homogeneity 2.

Fluid Composition Considerations

This solution (D5 1/2 NS) contains:

• 5% dextrose (50 g/L glucose)
• 0.45% sodium chloride (77 mEq/L sodium)
• 20 mEq/L potassium chloride (as added)

Population-Specific Concerns

Pediatric patients: This fluid composition (0.45% saline in 5% dextrose) has been associated with significant risk of hyponatremia in hospitalized children. Recent evidence shows that hypotonic fluids cause significantly more hyponatremia at 12 and 24 hours compared to isotonic fluids 3. The 175 mL/hr rate may exceed appropriate maintenance rates for many pediatric patients, which are typically calculated as 100 mL/kg/24h for the first 10 kg 4.

Adult patients: For most adults requiring maintenance fluids, this rate (175 mL/hr = 4.2 L/24hr) may be appropriate, but must be adjusted based on:

• Cardiac function (risk of fluid overload) 5
• Renal function (risk of hyperkalemia with potassium administration) 1
• Current electrolyte status

Monitoring Requirements

Essential monitoring includes:

• Serum potassium levels - check frequently, especially if patient receives digitalis or has renal insufficiency 1
• Serum sodium levels - particularly important with hypotonic solutions 3
• Blood glucose - the 5% dextrose can cause hyperglycemia, especially in critically ill patients 6
• Cardiac rhythm - continuous monitoring recommended for concentrated potassium infusions 1
• Fluid balance and signs of overload 5

Practical Administration Steps

1. Verify the prescription includes rate, concentration, and duration
2. Prepare the solution with independent double-check by second practitioner if institutional policy requires 7
3. Mix vigorously after adding KCl - invert bag multiple times to ensure homogeneous distribution 2
4. Label clearly - mark as containing potassium
5. Use infusion pump - never gravity drip 1
6. Establish IV access - preferably large peripheral vein or central line for this concentration
7. Initiate monitoring - cardiac monitor if available, baseline labs
8. Assess infusion site regularly for signs of infiltration or phlebitis (50% dextrose component can cause phlebitis) 5

Common Pitfalls to Avoid

• Inadequate mixing of potassium in the bag leads to dangerous concentration variability 2
• Rapid infusion of potassium can cause cardiac toxicity 1
• Using hypotonic fluids in children without considering hyponatremia risk 3
• Failing to monitor glucose in patients receiving dextrose-containing solutions 6
• Administering through small peripheral veins without considering phlebitis risk 5
• Confusing this solution with other IV fluids - D5 1/2 NS looks similar to plain NS 7